Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-09-11-Speech-2-372-125"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech²
dcterms:Date	"2012-09-11"^^xsd:date²
dcterms:Is Part Of	lp_eu:Explanations of vote²
dcterms:Language	"fr"^^xsd:language²
lpv:document identification number	"en.20120911.32.2-372-125"²
lpv:hasSubsequent	lp_eu:2012-09-11-Speech-2-372-187²
lpv:speaker	lp:Véronique Mathieu Houillon²
lpv:spokenAs	member; EPP (2009-07-14--2013-05-21)^3,3 unknown; Union pour un Mouvement Populaire - Parti Radical (2010-10-20--2013-04-14)^3,3 member; LIBE (2012-01-19--2014-06-30)^3,3 member; CRIM (2012-03-28--2013-10-23)^3,3 member; Delegation for relations with the countries of Southeast Asia and the Association of Southeast Asian Nations (ASEAN) (2010-05-17--2014-06-30)^3,3 substitute; Delegation for relations with the People's Republic of China (2011-09-07--2014-06-30)^3,3 substitute; AGRI (2012-01-19--2014-06-30)^3,3 substitute; CONT (2012-01-19--2014-06-30)^3,3
lpv:translated text	"I voted in favour of the report on pharmacovigilance at European level. In 2010, the European system already underwent considerable modernisation in order to allow for greater surveillance of medicines that appear on the market. Nevertheless, the stress test following the Mediator affair has shown that there is still room for improvement in the system. The new measures are therefore a positive step for patient safety."@en¹

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph